Work

Phase I dose escalation study of the anti-IGF-1R monoclonal antibody CP-751,871 in patients with refractory solid tumors

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3586

Authors: P. Haluska, H. Shaw, G. N. Batzel, L. R. Molife, A. A. Adjei, T. A. Yap, M. L. Roberts, A. Gualberto, J. S. de Bono

Institutions: Roswell Park Comprehensive Cancer Center, Mayo Clinic, Royal Marsden Hospital

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2207381344

Cites:

Cited by: 22

Related to: 10